Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

F Lordick; S Lorenzen; J Stollfuss; U Vehling-Kaiser; F Kullmann; M Hentrich; R Zumschlinge; H Dietzfelbinger; J Thoedtmann; M Hennig

doi:10.1038/sj.bjc.6602697

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

Identifier:nobleid.org/w1/20260515/CF86C079

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF86C079.svg?ark=w1%2F20260515%2FCF86C079)](https://nobleid.org/work/w1/20260515/CF86C079)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

Identifier:nobleid.org/w1/20260515/CF86C079

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF86C079.svg?ark=w1%2F20260515%2FCF86C079)](https://nobleid.org/work/w1/20260515/CF86C079)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work